Who Paid My Doc
Melanie Sion
Surgical Critical Care New Haven, CT Medical Doctor
NPI 1669790622 CMS profile 2781302
330 Cedar St # Bb310, New Haven, CT 06510
General payments
$9,103
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Melanie Sion of New Haven, CT is reported in the CMS Open Payments database as having received $9,103 across 7 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 84th percentile of Surgical Critical Care profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $52 | 1 | |
| 2021 | General | $9,050 | 6 |
Beside peers
- Melanie Sion
- Surgical Critical Care median
- Middle half of Surgical Critical Care
- National median
In program year 2025, general payments to Melanie Sion were reported at $0. Among 1,068 Surgical Critical Care profiles paid that year, the median was $231 and the middle half received between $82 and $1,489.
Show as a table
| Year | Melanie Sion | Surgical Critical Care median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $161 | $57–$631 | $163 |
| 2020 | $0 | $116 | $33–$383 | $114 |
| 2021 | $9,050 | $121 | $37–$475 | $132 |
| 2022 | $0 | $163 | $53–$789 | $149 |
| 2023 | $52 | $188 | $67–$1,031 | $160 |
| 2024 | $0 | $216 | $80–$1,133 | $164 |
| 2025 | $0 | $231 | $82–$1,489 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 22 billing codesPaid by Medicare
$29,919
Medicare patients
105
Services billed
187
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 58% | |
| Ischemic heart disease | 47% | |
| Diabetes | 46% | |
| Depression | 45% | |
| Heart failure | 43% | |
| Chronic kidney disease | 41% | |
| COPD | 38% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Surgical Critical Care in Connecticut
Philip Corvo
Surgical Critical Care · Waterbury, CT
David Shapiro
Surgical Critical Care · Hartford, CT
Eric Tsung
Surgical Critical Care · Bridgeport, CT
William Symons
Surgical Critical Care · Stamford, CT
Noubar Kevorkian
Surgical Critical Care · New Britain, CT
Shannon Small
Surgical Critical Care · New London, CT
Related records
Surgical Critical Care in Connecticut
Practitioners in the same specialty and state, ranked by reported value.
All Surgical Critical Care
Everyone recorded under this specialty, nationwide.
Doctors in Connecticut
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.